Roche
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.
In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.
Business & Industry
- US FDA grants Lynparza Orphan Drug Designation for pancreatic cancer
- Amgen launches AMGEVITATM (Biosimilar Adalimumab) In markets across Europe
- Novartis 5-year data in psoriatic arthritis and ankylosing spondylitis reinforces Cosentyx® leadership in spondyloarthritis
- Abbott names Robert B. Ford president, chief operating officer
- Boehringer Ingelheim increases awareness of health with the micro enterprise project 'Elephants' in South India
Research & Development
- Eating leafy greens could help prevent macular degeneration
- Targeted drugs for advanced cancer move from specialist units to community setting
- Diets rich in fish oil could slow the spread and growth of breast cancer cells
- Cancer stem cells use normal genes in abnormal ways
- Organs-on-chip technology reveals new drug candidates for Lou Gehrig's disease
- Seed oils are best for LDL cholesterol
- Could treating psoriasis in the future be as easy as going online?
Conferences & Events
- SMi Group announces the 10th Annual RNA Therapeutics Conference
- Pre-Filled Syringes & Injectable Drug Devices Europe 2018
- Social Media in the Pharmaceutical Industry Conference 2019
- Lyophilization USA Conference 2018
- SMi presents the 13th annual industry leading conference: Cold Chain Distribution
- Orphan Drugs and Rare Diseases Conference 2018
- Immuno-Oncology Conference 2018
Regulatory Affairs
- FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old
- FDA approves first treatment for advanced form of the second most common skin cancer
- FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
- FDA approves new kind of treatment for hairy cell leukemia
- FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease